Lipocine Inc. Files 8-K for Other Events and Exhibits
Ticker: LPCN · Form: 8-K · Filed: May 14, 2025 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financial Reporting
TL;DR
Lipocine filed an 8-K on 5/14/25 for other events and exhibits. Check filing for details.
AI Summary
Lipocine Inc. filed an 8-K on May 14, 2025, reporting on other events and financial statements. The filing does not detail specific transactions or financial figures but serves as a notification of these items. The company, incorporated in Delaware, operates in the Pharmaceutical Preparations sector.
Why It Matters
This 8-K filing indicates Lipocine Inc. is providing updates on its corporate activities and financial reporting to the SEC. Investors should review the full filing for details on any significant events or financial changes.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures, indicating no immediate new risks.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- May 14, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 675 Arapeen Drive, Suite 202 (address) — Principal Executive Offices
- Salt Lake City, Utah 84108 (address) — Principal Executive Offices
- 801-994-7383 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Lipocine Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of May 14, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 14, 2025.
In which state is Lipocine Inc. incorporated?
Lipocine Inc. is incorporated in Delaware.
What is Lipocine Inc.'s principal executive office address?
Lipocine Inc.'s principal executive office is located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.
What is the SIC code for Lipocine Inc.?
The Standard Industrial Classification (SIC) code for Lipocine Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Lipocine Inc. (LPCN).